The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1.

The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1.

Antibody protection against flaviviruses is associated with the development of neutralizing antibodies against the viral envelope (E) protein. Prior studies with West Nile virus (WNV) identified therapeutic mouse and human monoclonal antibodies (MAbs) that recognized epitopes on domain III (DIII) of...

Full description

Bibliographic Details
Main Authors:	Bimmi Shrestha, James D Brien, Soila Sukupolvi-Petty, S Kyle Austin, Melissa A Edeling, Taekyung Kim, Katie M O'Brien, Christopher A Nelson, Syd Johnson, Daved H Fremont, Michael S Diamond
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2010-04-01
Series:	PLoS Pathogens
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20369024/pdf/?tool=EBI

Similar Items

Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope.
by: S Kyle Austin, et al.
Published: (2012-01-01)

Potent dengue virus neutralization by a therapeutic antibody with low monovalent affinity requires bivalent engagement.
by: Melissa A Edeling, et al.
Published: (2014-04-01)

Correction: Therapeutic Efficacy of Antibodies Lacking Fc. Receptor Binding against Lethal Dengue Virus Infection Is Due to Neutralizing Potency and Blocking of Enhancing Antibodies.
by: Katherine L. Williams, et al.
Published: (2013-03-01)

Therapeutic efficacy of antibodies lacking Fcγ receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected].
by: Katherine L Williams, et al.
Published: (2013-02-01)

Genotype-specific and cross-reactive neutralizing antibodies induced by dengue virus infection: detection of antibodies with different levels of neutralizing activities against homologous and heterologous genotypes of dengue virus type 2 in common marmosets (Callithrix jacchus)
by: Nor Azila Muhammad Azami, et al.
Published: (2018-03-01)

The mechanistic basis of protection by non-neutralizing anti-alphavirus antibodies
by: James T. Earnest, et al.
Published: (2021-04-01)

A therapeutic antibody against west nile virus neutralizes infection by blocking fusion within endosomes.
by: Bruce S Thompson, et al.
Published: (2009-05-01)

Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs
by: Adea, K., et al.
Published: (2022)

Stimulation of homologous recombination in plants expressing heterologous recombinases
by: Abdellah Barakate, et al.
Published: (2020-07-01)

Catalytic antibodies elicited via homologous and heterologous immunization
by: Suga, Hiroaki, 1963-
Published: (2005)

Comparison of homologous and heterologous prime-boost vaccine approaches using Modified Vaccinia Ankara and soluble protein to induce neutralizing antibodies by the human cytomegalovirus pentamer complex in mice.
by: Flavia Chiuppesi, et al.
Published: (2017-01-01)

Incorporation of Homologous and Heterologous Proteins in the Saccharomyces cerevisiae Cell Wall
by: Renata Teparić, et al.
Published: (2010-01-01)

Reaktivitas Antibodi Poliklonal SSV terhadap Antigen Homolog dan Heterolog
by: Sri Sulandari, et al.
Published: (1998-07-01)

In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection.
by: Ruklanthi de Alwis, et al.
Published: (2011-06-01)

Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles.
by: Kelly L Warfield, et al.
Published: (2015-01-01)

Homologous and Heterologous Phosphorylations of Human Histamine H1 Receptor in Intact Cells
by: Katsuhiro Miyoshi, et al.
Published: (2004-01-01)

Metabolism of homologous and heterologous lipoproteins by cultured rat and human skin fibroblasts1
by: C A Drevon, et al.
Published: (1981-01-01)

Dengue outbreaks: Report of short heterologous protection in Reunion Island
by: M. Vincent, et al.
Published: (2020-12-01)

A molecular understanding of alphavirus entry.
by: Autumn C Holmes, et al.
Published: (2020-10-01)

Immunocytochemical identification of leishmania and Trypanosoma cruzi amastigotes in situ with homologous and heterologous polyclonal antibodies
by: A.J.A. Barbosa, et al.
Published: (1991-03-01)

ANTIGENIC RELATEDNESS OF SELECTED FLAVIVIRUSES: STUDY WITH HOMOLOGOUS AND HETEROLOGOUS IMMUNE MOUSE ASCITIC FLUIDS
by: S.S. BABA, et al.
Published: (1998-11-01)

Immunocytochemical identification of leishmania and Trypanosoma cruzi amastigotes in situ with homologous and heterologous polyclonal antibodies
by: A.J.A. Barbosa, et al.
Published: (1991-03-01)

Rates of neutralization and ionization constants of homologous nitrocycloalkanes.
by: Amburn, Hershel Walter
Published: (1968)

Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus.
by: Pankaj Pal, et al.
Published: (2013-01-01)

The K Domain Mediates Homologous and Heterologous Interactions Between FLC and SVP Proteins of Brassica juncea
by: Ma Guanpeng, et al.
Published: (2015-07-01)

Improving the homologous recombination efficiency of Yarrowia lipolytica by grafting heterologous component from Saccharomyces cerevisiae
by: Qingchun Ji, et al.
Published: (2020-12-01)

Previous homologous and heterologous stress exposure induces tolerance development to pulsed light in Listeria monocytogenes
by: Victoria eHeinrich, et al.
Published: (2016-04-01)

Listeria monocytogenes Response to Sublethal Chlorine Induced Oxidative Stress on Homologous and Heterologous Stress Adaptation
by: Mohit Bansal, et al.
Published: (2018-08-01)

Characterization of homologous and heterologous adaptive immune responses in porcine reproductive and respiratory syndrome virus infection
by: Díaz Ivan, et al.
Published: (2012-04-01)

Cross Protective Evaluation of Actinobacillus pleuropneumoniae Subunit Vaccine Against Homologous and Heterologous Serotypes Infection
by: Chun-Cheng Lin, et al.
Published: (2016)

Mouse Models of Heterologous Flavivirus Immunity: A Role for Cross-Reactive T Cells
by: Mariah Hassert, et al.
Published: (2019-05-01)

Investigation into metabolic profile changes in environmental hypoxia and the potential for dietary nitrate to alleviate hypoxic stress
by: O'Brien, Katie Alice
Published: (2017)

Capturing a flavivirus pre-fusion intermediate.
by: Bärbel Kaufmann, et al.
Published: (2009-11-01)

Microarray Analysis of <em>Streptococcus mutans</em> and <em>Actinomyces viscosus</em> in Homologous and Heterologous Cultures
by: Horton, Steven Andrew
Published: (2008)

Intradermal vaccination of live attenuated influenza vaccine protects mice against homologous and heterologous influenza challenges
by: Andrew Chak-Yiu Lee, et al.
Published: (2021-08-01)

Comparison of the protective antigen variabilities of prevalent Newcastle disease viruses in response to homologous/heterologous genotype vaccines
by: Yonghua Li, et al.
Published: (2021-08-01)

Assessing the immunogenicity and toxicity of the AFPL1-conjugate nicotine vaccine using heterologous and homologous vaccination routes.
by: Nya L Fraleigh, et al.
Published: (2019-01-01)

Distinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus Infections.
by: Jian-Da Lin, et al.
Published: (2016-04-01)

α1B-adrenergic receptors differentially associate with Rab proteins during homologous and heterologous desensitization.
by: Jean A Castillo-Badillo, et al.
Published: (2015-01-01)

gRNA Sequence Heterology Tolerance Catalyzed by CRISPR/Cas in an In Vitro Homology-Directed Repair Reaction
by: Amanda M. Hewes, et al.
Published: (2020-06-01)